
Pharmacally
Urticaria
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Urticaria
New Drug ApprovalDupixent Breaks New Ground in Pediatric Chronic Urticaria CareThe FDA has expanded Dupixent’s approval to include children aged two to 11 years with chronic spontaneous urticaria who remain symptomatic despite antihistamine therapy, supported by phase 3…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.